Abstract:A growing collection of evidence exists to support a role for non-neuronal cells in Alzheimer’s Disease (AD) pathogenesis. Although less widely studied, neuroimaging and neuropathology data suggests that dysregulation of oligodendrocytes (OLs) and subsequent dysmyelination of axons appears to be a critical initiating event in stimulating AD pathology. Despite these intriguing preliminary data, the precise molecular networks and genetic targets in OLs that are involved in initiating the AD process have yet to be elucidated. We applied a series of molecular network analysis techniques to a large data set of human postmortem gene expression data from AD patient brain samples, including coexpression networks, causal Bayesian networks, key driver analysis, and network annotation tools. This integrative network approach allowed us to integrate data from a diverse set of modalities and thereby identify critical pathways and genes that are altered within OLs in AD. We find that an AD coexpression network of OL-associated genes is not only highly correlated with AD pathological traits but also enriched for the known AD GWAS risk genes. Further, we demonstrate that this network is strongly dysregulated at the expression level in brain samples from AD patients. We further dissect the molecular regulation patterns of OLs in AD to identify key drivers of the OL network including PSEN1, UGT8, CNP, MYRF, and PLP1. We show that in vitro and in vivo perturbations of the key drivers within the gene-gene interaction network mimic key aspects of gene expression dysregulation in human AD brain samples. Our data also suggests PSEN1, whose mutations have been identified in early-onset familial AD, plays a key role in the dys-regulation of myelination in the more common late-onset AD. Our network analysis of oligodendrocytes in AD further strengthens the existing evidence that OLs play a role in AD. Importantly, our results also suggest key pathways through which OLs may help mediate AD pathogenesis.

Disease-associated oligodendroglia: a putative nexus in neurodegeneration

Disease-Associated Oligodendrocyte: New Player in Alzheimer's Disease and CNS Pathologies

Beyond Myelination: Possible Roles of the Immune Proteasome in Oligodendroglial Homeostasis and Dysfunction

Oligodendrocytes and myelin: Active players in neurodegenerative brains?

Author Correction: A Shared Disease-Associated Oligodendrocyte Signature among Multiple CNS Pathologies

Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage

Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?

Chronic oligodendrocyte injury in central nervous system pathologies

F2‐01‐01: Oligodendrocyte‐Enriched Gene Networks Reveal Novel Pathways and Key Targets in the Pathogenesis of Alzheimer’s Disease

Disease-associated microglia and activation of CD8 T cells precede neuronal cell loss in a model of hereditary spastic paraplegia

Microglia in Neurodegenerative Diseases

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation

Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications

Neuron to Oligodendrocyte Precursor Cell Synapses: Protagonists in Oligodendrocyte Development and Myelination, and Targets for Therapeutics

Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord

Disease-associated astrocytes in Alzheimer’s disease and aging

Neuroinflammation as a Common Feature of Neurodegenerative Disorders

Interactions Between Astrocytes and Oligodendroglia in Myelin Development and Related Brain Diseases

Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Altered human oligodendrocyte heterogeneity in multiple sclerosis